Back to Agenda
Day 2: Session 1: The Art of Writing Complex Safety Submission Document
Session Chair(s)
Avinash Kakade
Vice President and Head of Pharmacovigilance
Cipla, India
Speaker(s)
Day 2: Seesion 1: Consistent Messaging Across Safety Documents
Neeta Korlepara
Novartis Helathcare Pvt. Ltd., India
Manager
Ashish Indani, MD, ND
TCS, India
Domain Consultant - Senior Consultant
Day2: Session1: Critical Safety Reporting aspects related to FIH studies
Prajak Barde
Rhizen Pharmaceuticals S A, Switzerland
Director- Clinical Research
Have an account?